Ordinary folk, every newspaper and TV channel in the country, Congressmen (including the ones who were screaming for bank bailouts during 2008) and even people on the Wall Street (what an irony!) are furious that AIG should be paying some of its executives handsome bonuses while on the dole. The details of the AIG bailout that have been made public, reluctantly, by the government focus the spotlight more clearly on the faults of the system as a whole.
Under the proposed amendment to the environment clearance law, industries can expand simply by certifying that they are not polluting. Among the sectors that will benefit from this procedure are mining, power and petrochemicals, a range of manufacturing industries, in addition to dredging, shipping, port development, building and construction and industrial estates.
Importing the US system of food regulation to India could prove injurious to health.
Mesmerised by the cinematic kitsch of Mumbai's underbelly, Americans are seeking palliatives to the horror stories tumbling out of the Byzantine world of investment banking.
Pharmaceutical giant GlaxoSmithKline has slashed prices of drugs for the poorest countries and is sharing part of the profits with these countries to beef up health facilities. CEO Andrew Witty said, ' We have the capacity to do more and we can do more. The question is can we, big pharmaceutical companies, rise to the challenge and be a genuine catalyst for change?'
Industrialists benefit unduly from the Gujarat CM's largesse. Should they care about the decline in the social sector?
Two Delhi High Court judges have ignored statutory regulations and are seeking to mandate a link between drug regulation and patents where none exists in law, says Latha Jishnu.
Natural gas is clearly a Union subject but states and the courts have ignored this rule and added to the chaos, says Latha Jishnu.
Rich countries will use the Doha Round to shift the pain of the financial meltdown to developing countries.
It has a prized aroma, impeccabits pedigree and an awesome global reputation. None of this has helped Basmati to get the special label it deserves.
As turbines fail and costs shoot up, is anyone accountable for the mess at India's costliest power project.
The overriding image of the patent troll is of an entity that relentlessly hounds companies, individuals and institutions that it thinks has incorporated the IP in any patents that it owns in a product without due permission. Its main activity is the business of suing and it is a creature more reviled than the troll of mythology ever was, says Latha Jishnu.
Too much symbolism and emotion is invested in making cars for the masses.
How do you provide health care to handloom weavers, who occupy among the poorest segments in the unorganised sector? There are 6.5 million of them scattered across the country and are not always fixed in their occupation.
Microsoft, which is usually at the receiving end of patent suits, has filed an infringement case against Primax Electronics of Taiwan for using its mouse technology.
What we need is some informed debate on what is India's best interest at this particular stage instead of going for a wholesale import of an American system that could prove ineffectual.
Only a couple of specialty wire services in the US picked up this news; the mainstream press ignored what appears to be a marked -- and dramatic shift -- in the approach to drug discovery. What we are seeing is the first big bang contribution to open source drug discovery, an initiative to rope in researchers, universities and companies to make drug breakthroughs less expensive and time-consuming.
When the International Labour Organisation appointed Assane Diop as executive director to kick off its social protection initiative in 2000, it couldn't have found a man with better credentials for the job.
Patent reform in the US is on hold indefinitely.
India's decision to join the Turkmenistan pipeline project which is more hazardous than the Iranian channel is puzzling.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances